PREDNISOLONE ACETATE

PREDNISOLONE ACETATE was reported 11313 times

PREDNISOLONE ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NPM1 GENE MUTATION 10 0.7143
1 INFECTIOUS CRYSTALLINE KERATOPATHY 13 0.3514
2 ACANTHAMOEBA KERATITIS 8 0.2162
3 SERPIGINOUS CHOROIDITIS 8 0.1667
4 INFECTIVE KERATITIS 10 0.1408
5 KERATITIS FUNGAL 24 0.1154
6 CHIMERISM 10 0.1124
7 CORNEAL EPITHELIUM DEFECT 62 0.1067
8 CORNEAL GRAFT REJECTION 21 0.1000
9 HAEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS 7 0.0959
10 CORNEAL INFILTRATES 29 0.0924
11 CHOROIDITIS 33 0.0882
12 KERATITIS BACTERIAL 14 0.0859
13 PERSISTENT CORNEAL EPITHELIAL DEFECT 10 0.0847
14 TRACTIONAL RETINAL DETACHMENT 9 0.0811
15 RECALLED PRODUCT ADMINISTERED 764 0.0800
16 CONJUNCTIVAL ULCER 11 0.0797
17 ANTERIOR CHAMBER FIBRIN 10 0.0775
18 NECROTISING SCLERITIS 10 0.0690
19 SCLERAL THINNING 7 0.0660
20 CORNEAL TRANSPLANT 51 0.0651
21 RHEGMATOGENOUS RETINAL DETACHMENT 13 0.0622
22 CORNEAL THINNING 15 0.0584
23 BRONCHIOLITIS OBLITERANS SYNDROME 10 0.0571
24 TOXIC ANTERIOR SEGMENT SYNDROME 62 0.0568
25 CORNEAL SCAR 26 0.0517
26 ANTERIOR CHAMBER CELL 36 0.0504
27 EYE OPERATION COMPLICATION 8 0.0488
28 CORNEAL DEPOSITS 34 0.0457
29 CORNEAL OPACITY 62 0.0454
30 HYPOTONY OF EYE 19 0.0452
31 FLAT ANTERIOR CHAMBER OF EYE 8 0.0447
32 IRIS ATROPHY 9 0.0435
33 CORNEAL OEDEMA 96 0.0428
34 HYPOPYON 35 0.0423
35 CATARACT SUBCAPSULAR 25 0.0410
36 SCLERAL DISORDER 11 0.0407
37 PUNCTATE KERATITIS 37 0.0403
38 PERIORBITAL PAIN 32 0.0378
39 DEAFNESS PERMANENT 7 0.0357
40 CSF PRESSURE INCREASED 9 0.0338
41 CORNEAL PERFORATION 21 0.0333
42 FIBROUS HISTIOCYTOMA 11 0.0313
43 EYELID PAIN 63 0.0310
44 HYPHAEMA 16 0.0307
45 ENDOPHTHALMITIS 184 0.0306
46 CORNEAL DISORDER 67 0.0305
47 NEOVASCULARISATION 8 0.0304
48 FOREIGN BODY IN EYE 28 0.0292
49 INJURY CORNEAL 15 0.0288
50 EYE INFECTION FUNGAL 11 0.0284
51 CORNEAL NEOVASCULARISATION 7 0.0283
52 TUBULOINTERSTITIAL NEPHRITIS AND UVEITIS SYNDROME 7 0.0283
53 EYE INFECTION VIRAL 9 0.0280
54 IRIS ADHESIONS 14 0.0273
55 PRODUCT DROPPER ISSUE 21 0.0267
56 INTRAOCULAR PRESSURE DECREASED 14 0.0266
57 CYSTOID MACULAR OEDEMA 48 0.0255
58 EPIRETINAL MEMBRANE 7 0.0252
59 ACOUSTIC NEUROMA 10 0.0244
60 ULCERATIVE KERATITIS 67 0.0244
61 VITRECTOMY 13 0.0218
62 NECROTISING RETINITIS 13 0.0203
63 EYE INFECTION TOXOPLASMAL 8 0.0202
64 SUPERFICIAL INJURY OF EYE 22 0.0201
65 VITRITIS 37 0.0200
66 FOREIGN BODY SENSATION IN EYES 127 0.0199
67 COMPLICATIONS OF TRANSPLANT SURGERY 10 0.0198
68 INTRAOCULAR PRESSURE INCREASED 253 0.0198
69 OCULAR HYPERTENSION 38 0.0196
70 ASTIGMATISM 29 0.0191
71 CORNEAL ABRASION 26 0.0190
72 CORYNEBACTERIUM INFECTION 10 0.0187
73 VITREOUS OPACITIES 15 0.0178
74 EYE ULCER 10 0.0174
75 ENDOCRINE OPHTHALMOPATHY 15 0.0173
76 SCLERITIS 27 0.0168
77 IRITIS 51 0.0168
78 RETINAL ISCHAEMIA 10 0.0164
79 RETINAL PIGMENT EPITHELIOPATHY 7 0.0162
80 EYE INFECTION BACTERIAL 9 0.0161
81 KERATITIS 48 0.0158
82 GLARE 8 0.0156
83 TREATMENT FAILURE 1267 0.0153
84 ANTERIOR CHAMBER INFLAMMATION 9 0.0151
85 RETINAL VASCULITIS 18 0.0151
86 PUPILLARY DISORDER 9 0.0148
87 IRIDOCYCLITIS 46 0.0145
88 CHOROIDAL DETACHMENT 8 0.0144
89 EYE PAIN 800 0.0142
90 KERATOPATHY 22 0.0139
91 OPHTHALMIC HERPES SIMPLEX 8 0.0139
92 HALO VISION 15 0.0133
93 EYE INFLAMMATION 124 0.0130
94 NON-INFECTIOUS ENDOPHTHALMITIS 11 0.0130
95 CATARACT NUCLEAR 8 0.0120
96 OCULAR DISCOMFORT 133 0.0118
97 MACULAR FIBROSIS 8 0.0118
98 OPEN ANGLE GLAUCOMA 7 0.0114
99 INTRAOCULAR PRESSURE TEST ABNORMAL 8 0.0113
100 UVEITIS 154 0.0113
101 HERPES OPHTHALMIC 14 0.0106
102 VITREOUS HAEMORRHAGE 29 0.0105
103 DEEP VEIN THROMBOSIS POSTOPERATIVE 21 0.0105
104 EPISCLERITIS 7 0.0101
105 CHOROIDAL EFFUSION 8 0.0100
106 PHOTOPHOBIA 187 0.0099
107 PRODUCT LOT NUMBER ISSUE 22 0.0099
108 BLADDER TRANSITIONAL CELL CARCINOMA 14 0.0098
109 CONJUNCTIVAL OEDEMA 10 0.0097
110 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 9 0.0095
111 EYE DISCHARGE 93 0.0089
112 EYE OPERATION 41 0.0089
113 BENIGN INTRACRANIAL HYPERTENSION 11 0.0088
114 CYTOMEGALOVIRUS CHORIORETINITIS 17 0.0087
115 STEROID DIABETES 13 0.0087
116 EYE IRRITATION 477 0.0083
117 RETINAL TEAR 20 0.0081
118 PRODUCT EXPIRATION DATE ISSUE 11 0.0078
119 OPHTHALMIC HERPES ZOSTER 14 0.0078
120 ABNORMAL SENSATION IN EYE 33 0.0077
121 PRODUCT DELIVERY MECHANISM ISSUE 41 0.0076
122 CONJUNCTIVAL HYPERAEMIA 27 0.0076
123 EYELID IRRITATION 19 0.0076
124 RETINAL OEDEMA 14 0.0073
125 OCULAR HYPERAEMIA 343 0.0072
126 GLAUCOMA 137 0.0071
127 MACULAR OEDEMA 39 0.0070
128 RETINAL DETACHMENT 63 0.0068
129 CONJUNCTIVITIS ALLERGIC 10 0.0067
130 PRODUCT CONTAINER ISSUE 57 0.0066
131 EYELID MARGIN CRUSTING 19 0.0066
132 VISUAL ACUITY REDUCED 212 0.0064
133 SWELLING OF EYELID 40 0.0064
134 EYE INFECTION 71 0.0063
135 ANGLE CLOSURE GLAUCOMA 16 0.0063
136 LIQUID PRODUCT PHYSICAL ISSUE 44 0.0060
137 ESSENTIAL HYPERTENSION 11 0.0060
138 VITREOUS FLOATERS 59 0.0060
139 BLINDNESS UNILATERAL 81 0.0057
140 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 8 0.0057
141 INCORRECT DOSE ADMINISTERED BY PRODUCT 9 0.0056
142 VITREOUS DETACHMENT 12 0.0055
143 METAMORPHOPSIA 10 0.0054
144 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 11 0.0053
145 TRANSPLANT FAILURE 13 0.0053
146 COMPLICATIONS OF TRANSPLANTED KIDNEY 12 0.0053
147 BLEPHARITIS 21 0.0052
148 RADIATION PNEUMONITIS 11 0.0051
149 ACUTE MYELOID LEUKAEMIA RECURRENT 11 0.0051
150 DRUG DELIVERY SYSTEM ISSUE 10 0.0051
151 CYTOMEGALOVIRUS TEST POSITIVE 9 0.0050
152 LIVER TRANSPLANT REJECTION 9 0.0050
153 LACRIMATION INCREASED 151 0.0050
154 NEPHROGENIC ANAEMIA 23 0.0050
155 OPTIC ATROPHY 8 0.0049
156 CATARACT OPERATION 29 0.0049
157 DEAFNESS NEUROSENSORY 16 0.0049
158 DISLOCATION OF VERTEBRA 11 0.0048
159 MEDICATION RESIDUE PRESENT 23 0.0048
160 CATARACT 286 0.0048
161 RECALLED PRODUCT 8 0.0046
162 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 8 0.0045
163 EYE ALLERGY 7 0.0045
164 PRODUCT DEPOSIT 7 0.0045
165 EYE SWELLING 167 0.0045
166 BLOOD IMMUNOGLOBULIN G DECREASED 11 0.0044
167 DUODENAL ULCER PERFORATION 33 0.0044
168 HYPERPARATHYROIDISM SECONDARY 11 0.0044
169 MUSCLE INJURY 36 0.0043
170 PRODUCT CONTAMINATION PHYSICAL 11 0.0043
171 BREAST CANCER STAGE III 28 0.0043
172 PERIPHERAL VENOUS DISEASE 17 0.0042
173 HELICOBACTER INFECTION 42 0.0041
174 EYE OEDEMA 10 0.0041
175 PERIORBITAL SWELLING 23 0.0041
176 TREATMENT DELAYED 7 0.0040
177 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 11 0.0040
178 PANCREATIC FAILURE 7 0.0040
179 RETINAL ARTERY OCCLUSION 10 0.0040
180 EYE INJURY 12 0.0039
181 ERYTHEMA OF EYELID 21 0.0039
182 RETINAL DISORDER 10 0.0038
183 NO ADVERSE EVENT 682 0.0038
184 CONJUNCTIVAL HAEMORRHAGE 14 0.0037
185 INSTILLATION SITE PAIN 9 0.0036
186 IDIOPATHIC INTRACRANIAL HYPERTENSION 8 0.0036
187 TRANSPLANT REJECTION 28 0.0035
188 HORDEOLUM 15 0.0035
189 EYE DISORDER 113 0.0034
190 VISION BLURRED 470 0.0034
191 OPTIC NEUROPATHY 7 0.0033
192 THROMBOCYTOSIS 12 0.0033
193 DRY EYE 162 0.0032
194 IMMOBILE 14 0.0032
195 HAND DEFORMITY 42 0.0032
196 BLOOD BLISTER 10 0.0032
197 CONJUNCTIVITIS 59 0.0032
198 BLOOD PRESSURE DIASTOLIC ABNORMAL 8 0.0031
199 KIDNEY TRANSPLANT REJECTION 15 0.0031
200 MACULOPATHY 11 0.0031
201 PAPILLOEDEMA 14 0.0031
202 BLINDNESS 126 0.0031
203 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 22 0.0031
204 FACIAL PAIN 27 0.0030
205 BLOOD CULTURE POSITIVE 9 0.0030
206 PHOTOPSIA 19 0.0030
207 PEMPHIGUS 37 0.0030
208 EXOSTOSIS 27 0.0030
209 RETINOPATHY 11 0.0029
210 ASTHENOPIA 16 0.0029
211 HYPERCHOLESTEROLAEMIA 28 0.0029
212 SERUM SICKNESS 8 0.0029
213 EYE HAEMORRHAGE 38 0.0028
214 IMMUNOSUPPRESSION 25 0.0028
215 IMPAIRED HEALING 91 0.0028
216 AUTOIMMUNE DISORDER 27 0.0028
217 EYE PRURITUS 93 0.0028
218 LIP DRY 25 0.0027
219 PRODUCT PHYSICAL CONSISTENCY ISSUE 15 0.0027
220 RHEUMATIC FEVER 12 0.0027
221 PRODUCT USE COMPLAINT 42 0.0027
222 DIABETIC RETINOPATHY 9 0.0026
223 NAIL DISORDER 23 0.0026
224 FIBROSIS 8 0.0026
225 PRODUCT RESIDUE PRESENT 14 0.0026
226 GASTRIC PERFORATION 7 0.0026
227 DYSLIPIDAEMIA 13 0.0026
228 INFUSION SITE PRURITUS 8 0.0025
229 JOINT RANGE OF MOTION DECREASED 34 0.0025
230 PRODUCT ADMINISTRATION ERROR 51 0.0025
231 FOLLICULITIS 26 0.0025
232 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 16 0.0025
233 RETINAL VEIN OCCLUSION 7 0.0024
234 RETINAL HAEMORRHAGE 17 0.0024
235 INFUSION SITE SWELLING 15 0.0024
236 GRAFT VERSUS HOST DISEASE 17 0.0024
237 EYELID PTOSIS 24 0.0024
238 BLINDNESS TRANSIENT 17 0.0023
239 DIVERTICULUM INTESTINAL 10 0.0023
240 GRIP STRENGTH DECREASED 20 0.0023
241 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 17 0.0023
242 PHYSICAL DISABILITY 10 0.0023
243 VISUAL IMPAIRMENT 279 0.0022
244 RHEUMATOID FACTOR POSITIVE 13 0.0022
245 PRODUCT CONTAMINATION 8 0.0022
246 CUTANEOUS VASCULITIS 8 0.0022
247 PNEUMONIA BACTERIAL 20 0.0022
248 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 11 0.0022
249 BACTERIAL SEPSIS 7 0.0021
250 GLOSSODYNIA 48 0.0021
251 HAEMODIALYSIS 18 0.0021
252 PRODUCT COLOUR ISSUE 11 0.0021
253 ATRIAL FLUTTER 17 0.0021
254 INFUSION SITE HAEMORRHAGE 7 0.0021
255 VAGINAL INFECTION 10 0.0021
256 SKIN ABRASION 10 0.0021
257 INCORRECT DRUG ADMINISTRATION RATE 9 0.0021
258 PSEUDOMONAS INFECTION 18 0.0021
259 OBESITY 33 0.0021
260 THROMBOTIC MICROANGIOPATHY 20 0.0021
261 IRRITABLE BOWEL SYNDROME 44 0.0021
262 CONTRAINDICATED PRODUCT ADMINISTERED 61 0.0020
263 CYTOMEGALOVIRUS INFECTION 33 0.0020
264 CYSTITIS HAEMORRHAGIC 8 0.0020
265 BONE EROSION 7 0.0020
266 EYELID OEDEMA 23 0.0020
267 KLEBSIELLA INFECTION 10 0.0020
268 UROSEPSIS 18 0.0019
269 CHRONIC GRAFT VERSUS HOST DISEASE 7 0.0019
270 SPINAL STENOSIS 8 0.0019
271 LIVE BIRTH 16 0.0019
272 PARADOXICAL DRUG REACTION 7 0.0019
273 RED BLOOD CELL SEDIMENTATION RATE INCREASED 21 0.0019
274 PARANASAL SINUS DISCOMFORT 7 0.0018
275 HAEMORRHOIDAL HAEMORRHAGE 9 0.0018
276 DIVERTICULUM 13 0.0018
277 OPTIC ISCHAEMIC NEUROPATHY 7 0.0018
278 PULMONARY ALVEOLAR HAEMORRHAGE 10 0.0018
279 PRODUCT LEAKAGE 10 0.0018
280 TRISMUS 9 0.0017
281 MALIGNANT MELANOMA 23 0.0017
282 FOOT DEFORMITY 19 0.0017
283 SEASONAL ALLERGY 24 0.0017
284 BLOOD IRON DECREASED 20 0.0017
285 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 7 0.0017
286 BRONCHOPULMONARY ASPERGILLOSIS 13 0.0017
287 ASPERGILLUS INFECTION 11 0.0017
288 OSTEOARTHRITIS 71 0.0017
289 VISUAL FIELD DEFECT 12 0.0017
290 ADRENAL INSUFFICIENCY 20 0.0016
291 WOUND INFECTION 18 0.0016
292 PRODUCT DISPENSING ISSUE 7 0.0016
293 HAEMATOCRIT DECREASED 32 0.0016
294 RESPIRATORY SYNCYTIAL VIRUS INFECTION 14 0.0016
295 BLEPHAROSPASM 10 0.0016
296 EAR INFECTION 42 0.0016
297 SUSPECTED OFF LABEL USE 7 0.0015
298 THERAPY PARTIAL RESPONDER 24 0.0015
299 TENDERNESS 16 0.0015
300 INFLAMMATION 79 0.0015
301 HYPOGAMMAGLOBULINAEMIA 10 0.0015
302 ORAL CANDIDIASIS 20 0.0015
303 POST PROCEDURAL COMPLICATION 29 0.0015
304 LOWER LIMB FRACTURE 29 0.0015
305 POST PROCEDURAL INFECTION 12 0.0015
306 PRODUCT LABEL ISSUE 10 0.0015
307 PRODUCT PACKAGING ISSUE 14 0.0015
308 HYDRONEPHROSIS 11 0.0015
309 LIVER INJURY 36 0.0015
310 CONCOMITANT DISEASE AGGRAVATED 9 0.0015
311 JOINT EFFUSION 10 0.0014
312 ATELECTASIS 14 0.0014
313 ENTEROCOCCAL INFECTION 7 0.0014
314 STREPTOCOCCAL INFECTION 8 0.0014
315 STAPHYLOCOCCAL SEPSIS 7 0.0014
316 SINUS CONGESTION 19 0.0014
317 MULTIPLE ALLERGIES 11 0.0014
318 BURSITIS 17 0.0014
319 BACTERIAL INFECTION 26 0.0014
320 BLOOD LACTATE DEHYDROGENASE INCREASED 22 0.0014
321 LOW BIRTH WEIGHT BABY 11 0.0014
322 RALES 8 0.0014
323 END STAGE RENAL DISEASE 25 0.0014
324 PERICARDITIS 23 0.0014
325 FAILURE TO THRIVE 7 0.0013
326 ESCHERICHIA INFECTION 11 0.0013
327 BLOOD LACTIC ACID INCREASED 7 0.0013
328 SCIATICA 21 0.0013
329 ECCHYMOSIS 9 0.0013
330 INFUSION SITE ERYTHEMA 11 0.0013
331 DIFFUSE LARGE B-CELL LYMPHOMA 10 0.0013
332 DECREASED ACTIVITY 14 0.0013
333 ELECTROLYTE IMBALANCE 15 0.0013
334 OSTEOPOROSIS 53 0.0013
335 VITAMIN D DECREASED 11 0.0013
336 FLANK PAIN 12 0.0013
337 SYNOVITIS 23 0.0013
338 NEUTROPHIL COUNT INCREASED 13 0.0013
339 FOOT FRACTURE 24 0.0013
340 DISABILITY 25 0.0013
341 DEVICE USE ISSUE 22 0.0013
342 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
343 IMPAIRED QUALITY OF LIFE 18 0.0013
344 MYDRIASIS 16 0.0012
345 ROTATOR CUFF SYNDROME 16 0.0012
346 DISCOMFORT 76 0.0012
347 INFUSION SITE PAIN 16 0.0012
348 FIBROMYALGIA 30 0.0012
349 POOR QUALITY PRODUCT ADMINISTERED 13 0.0012
350 DIPLOPIA 32 0.0012
351 MAJOR DEPRESSION 9 0.0012
352 HERPES SIMPLEX 8 0.0012
353 SHOCK HAEMORRHAGIC 10 0.0012
354 GASTROINTESTINAL INFECTION 11 0.0012
355 CYTOPENIA 15 0.0012
356 CHRONIC KIDNEY DISEASE 93 0.0012
357 BEDRIDDEN 16 0.0012
358 BODY HEIGHT DECREASED 13 0.0012
359 MOUTH SWELLING 7 0.0012
360 SINUS DISORDER 24 0.0012
361 PANCREATITIS ACUTE 27 0.0012
362 PNEUMOTHORAX 19 0.0012
363 BACTERAEMIA 14 0.0012
364 NIGHT SWEATS 38 0.0012
365 THERAPY NON-RESPONDER 53 0.0012
366 INFUSION RELATED REACTION 78 0.0012
367 MYELODYSPLASTIC SYNDROME 17 0.0012
368 HYPERLIPIDAEMIA 14 0.0012
369 RENAL FAILURE CHRONIC 9 0.0012
370 LEUKOCYTOSIS 21 0.0012
371 SQUAMOUS CELL CARCINOMA OF SKIN 7 0.0012
372 NEURALGIA 28 0.0012
373 INGUINAL HERNIA 7 0.0011
374 MITRAL VALVE INCOMPETENCE 13 0.0011
375 DRUG-INDUCED LIVER INJURY 36 0.0011
376 GROIN PAIN 10 0.0011
377 SPINAL OSTEOARTHRITIS 10 0.0011
378 CHOLANGITIS 7 0.0011
379 PHARYNGITIS 14 0.0011
380 BLOOD PRESSURE SYSTOLIC INCREASED 22 0.0011
381 SINUSITIS 115 0.0011
382 RENAL TUBULAR NECROSIS 11 0.0011
383 EPSTEIN-BARR VIRUS INFECTION 7 0.0011
384 INTERSTITIAL LUNG DISEASE 54 0.0011
385 PANCYTOPENIA 62 0.0011
386 COLITIS ULCERATIVE 49 0.0011
387 SECOND PRIMARY MALIGNANCY 9 0.0011
388 EPILEPSY 33 0.0011
389 OBSTRUCTIVE AIRWAYS DISORDER 12 0.0011
390 SENSATION OF FOREIGN BODY 9 0.0011
391 ARTERIOSCLEROSIS CORONARY ARTERY 7 0.0011
392 APPETITE DISORDER 7 0.0011
393 SKIN HYPERPIGMENTATION 9 0.0010
394 ANURIA 9 0.0010
395 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
396 MOUTH ULCERATION 22 0.0010
397 HEPATIC ENZYME INCREASED 71 0.0010
398 FEBRILE NEUTROPENIA 69 0.0010
399 BRONCHIECTASIS 7 0.0010
400 SINUS BRADYCARDIA 10 0.0010
401 STAPHYLOCOCCAL INFECTION 34 0.0010
402 HYPOALBUMINAEMIA 8 0.0010
403 VITAMIN D DEFICIENCY 10 0.0010
404 MATERNAL EXPOSURE BEFORE PREGNANCY 7 0.0010
405 STOMATITIS 62 0.0010
406 TRICUSPID VALVE INCOMPETENCE 8 0.0010
407 GINGIVAL PAIN 8 0.0010
408 MACULAR DEGENERATION 12 0.0010
409 TOOTH FRACTURE 11 0.0010
410 CYTOKINE RELEASE SYNDROME 20 0.0010
411 UPPER RESPIRATORY TRACT INFECTION 46 0.0010
412 FUNGAL INFECTION 33 0.0010
413 ACUTE RESPIRATORY FAILURE 19 0.0010
414 LUNG DISORDER 48 0.0010
415 GLOMERULAR FILTRATION RATE DECREASED 12 0.0010
416 EAR DISCOMFORT 10 0.0010
417 UPPER-AIRWAY COUGH SYNDROME 8 0.0010
418 DERMATITIS CONTACT 11 0.0010
419 NEPHROPATHY 9 0.0010
420 FAECES SOFT 7 0.0010
421 HEAD DISCOMFORT 17 0.0010
422 FRACTURE 18 0.0009
423 BLOOD PRESSURE DIASTOLIC DECREASED 7 0.0009
424 CONDITION AGGRAVATED 288 0.0009
425 LOWER GASTROINTESTINAL HAEMORRHAGE 7 0.0009
426 ARTHROPOD BITE 7 0.0009
427 PROSTATIC SPECIFIC ANTIGEN INCREASED 13 0.0009
428 SLEEP APNOEA SYNDROME 18 0.0009
429 GASTROENTERITIS VIRAL 17 0.0009
430 RESTLESS LEGS SYNDROME 17 0.0009
431 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 51 0.0009
432 BLISTER 52 0.0009
433 MUSCLE STRAIN 8 0.0009
434 ECONOMIC PROBLEM 14 0.0009
435 LOWER RESPIRATORY TRACT INFECTION 42 0.0009
436 OSTEOPENIA 14 0.0009
437 RESPIRATORY TRACT INFECTION 24 0.0009
438 INFLAMMATORY BOWEL DISEASE 9 0.0009
439 RENAL FAILURE 122 0.0009
440 POLYNEUROPATHY 11 0.0009
441 DRUG DISPENSING ERROR 14 0.0009
442 PULMONARY HYPERTENSION 19 0.0009
443 HOSPICE CARE 9 0.0009
444 TUMOUR LYSIS SYNDROME 8 0.0009
445 HYPOXIA 32 0.0009
446 LYMPHOMA 14 0.0009
447 PURPURA 8 0.0009
448 CONCUSSION 7 0.0009
449 ARTHROPATHY 50 0.0009
450 TOOTH DISORDER 20 0.0009
451 COLITIS 34 0.0009
452 PULMONARY HAEMORRHAGE 7 0.0009
453 ELECTROCARDIOGRAM ABNORMAL 7 0.0009
454 JOINT INJURY 19 0.0009
455 HERPES ZOSTER 51 0.0009
456 BLOOD ALKALINE PHOSPHATASE INCREASED 22 0.0009
457 ILEUS 11 0.0009
458 ASPARTATE AMINOTRANSFERASE INCREASED 47 0.0009
459 THERAPY INTERRUPTED 63 0.0009
460 RENAL CYST 7 0.0009
461 PULMONARY MASS 13 0.0009
462 TINNITUS 40 0.0009
463 LOCALISED INFECTION 21 0.0009
464 RHINITIS 7 0.0009
465 IRON DEFICIENCY ANAEMIA 8 0.0009
466 DELIRIUM 30 0.0009
467 OFF LABEL USE 750 0.0009
468 HYPERKALAEMIA 30 0.0009
469 TUBULOINTERSTITIAL NEPHRITIS 16 0.0009
470 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 41 0.0009
471 HICCUPS 7 0.0009
472 INSURANCE ISSUE 13 0.0008
473 SQUAMOUS CELL CARCINOMA 8 0.0008
474 HIATUS HERNIA 11 0.0008
475 CLOSTRIDIUM DIFFICILE COLITIS 9 0.0008
476 PHARMACEUTICAL PRODUCT COMPLAINT 22 0.0008
477 SYSTEMIC LUPUS ERYTHEMATOSUS 30 0.0008
478 HYPOKALAEMIA 39 0.0008
479 TENDONITIS 13 0.0008
480 BLOOD UREA INCREASED 14 0.0008
481 INFECTION 121 0.0008
482 RHINORRHOEA 54 0.0008
483 JOINT SWELLING 100 0.0008
484 HEAD INJURY 26 0.0008
485 URINARY TRACT INFECTION 140 0.0008
486 HAEMORRHOIDS 16 0.0008
487 HEPATOMEGALY 8 0.0008
488 GAMMA-GLUTAMYLTRANSFERASE INCREASED 18 0.0008
489 BLOOD MAGNESIUM DECREASED 7 0.0008
490 HYPERCALCAEMIA 10 0.0008
491 NERVE INJURY 9 0.0008
492 LIGAMENT SPRAIN 8 0.0008
493 PYELONEPHRITIS 7 0.0008
494 MATERNAL EXPOSURE DURING PREGNANCY 72 0.0008
495 ORAL PAIN 18 0.0008
496 SNEEZING 18 0.0008
497 PRESCRIBED UNDERDOSE 16 0.0008
498 BACK DISORDER 13 0.0008
499 HEPATIC CIRRHOSIS 15 0.0008
500 PNEUMOCYSTIS JIROVECII PNEUMONIA 8 0.0008
501 MOBILITY DECREASED 57 0.0008
502 LIVER FUNCTION TEST INCREASED 17 0.0008
503 TOXIC EPIDERMAL NECROLYSIS 12 0.0008
504 PROTEINURIA 15 0.0008
505 ARTHRITIS 62 0.0008
506 PLATELET COUNT DECREASED 84 0.0008
507 DRUG LEVEL DECREASED 8 0.0008
508 RIB FRACTURE 16 0.0008
509 HIP FRACTURE 25 0.0008
510 PAIN IN JAW 22 0.0008
511 DRUG INTOLERANCE 75 0.0008
512 PRODUCT DOSE OMISSION ISSUE 228 0.0008
513 VENTRICULAR EXTRASYSTOLES 8 0.0008
514 ACUTE MYELOID LEUKAEMIA 12 0.0008
515 HYPERTENSION 163 0.0008
516 HEART RATE DECREASED 27 0.0008
517 SPLENOMEGALY 9 0.0008
518 ALANINE AMINOTRANSFERASE INCREASED 47 0.0008
519 COVID-19 PNEUMONIA 9 0.0008
520 INCREASED TENDENCY TO BRUISE 7 0.0008
521 HYPERSENSITIVITY 141 0.0008
522 SCRATCH 8 0.0008
523 RESPIRATORY TRACT CONGESTION 12 0.0008
524 BLOOD PRESSURE ABNORMAL 15 0.0008
525 RESPIRATORY FAILURE 55 0.0008
526 RENAL FAILURE ACUTE 32 0.0008
527 MULTI-ORGAN FAILURE 13 0.0008
528 WOUND 21 0.0008
529 ATRIAL FIBRILLATION 73 0.0007
530 QUALITY OF LIFE DECREASED 10 0.0007
531 MUSCULOSKELETAL PAIN 39 0.0007
532 SEPSIS 83 0.0007
533 DYSPNOEA EXERTIONAL 28 0.0007
534 CEREBRAL INFARCTION 18 0.0007
535 DISEASE RECURRENCE 35 0.0007
536 SKIN LACERATION 8 0.0007
537 PERICARDIAL EFFUSION 17 0.0007
538 PRODUCT DISPENSING ERROR 16 0.0007
539 RED BLOOD CELL COUNT DECREASED 21 0.0007
540 PULMONARY THROMBOSIS 8 0.0007
541 ENCEPHALOPATHY 18 0.0007
542 ACUTE KIDNEY INJURY 112 0.0007
543 BLOOD POTASSIUM DECREASED 22 0.0007
544 MELAENA 16 0.0007
545 SLEEP DISORDER 51 0.0007
546 LIVER DISORDER 32 0.0007
547 DRUG INEFFECTIVE 951 0.0007
548 RECTAL HAEMORRHAGE 31 0.0007
549 EAR PAIN 14 0.0007
550 OSTEOMYELITIS 13 0.0007
551 MALNUTRITION 8 0.0007
552 CARPAL TUNNEL SYNDROME 10 0.0007
553 BLOOD CALCIUM DECREASED 8 0.0007
554 DISSEMINATED INTRAVASCULAR COAGULATION 10 0.0007
555 PLEURAL EFFUSION 43 0.0007
556 SWELLING FACE 46 0.0007
557 OEDEMA PERIPHERAL 86 0.0007
558 HYPOPHAGIA 18 0.0007
559 BRONCHITIS 52 0.0007
560 SCAR 12 0.0007
561 LIMB INJURY 19 0.0007
562 HEPATIC FUNCTION ABNORMAL 26 0.0007
563 EMPHYSEMA 7 0.0007
564 WHEEZING 41 0.0007
565 TASTE DISORDER 14 0.0007
566 PNEUMONIA 223 0.0007
567 TOOTH ABSCESS 7 0.0007
568 MUSCULAR WEAKNESS 78 0.0007
569 INTENTIONAL PRODUCT USE ISSUE 60 0.0007
570 SPINAL PAIN 8 0.0007
571 GASTROINTESTINAL HAEMORRHAGE 57 0.0007
572 HAEMOGLOBIN DECREASED 70 0.0007
573 POOR VENOUS ACCESS 7 0.0007
574 CONTUSION 65 0.0007
575 BLOOD PRESSURE INCREASED 103 0.0007
576 PRESCRIBED OVERDOSE 13 0.0007
577 PETECHIAE 7 0.0007
578 IMMUNODEFICIENCY 10 0.0007
579 PRODUCT USE ISSUE 126 0.0007
580 PRODUCT TASTE ABNORMAL 9 0.0007
581 OEDEMA 36 0.0007
582 NEUROPATHY PERIPHERAL 63 0.0007
583 JOINT DISLOCATION 7 0.0007
584 TACHYPNOEA 9 0.0007
585 NASOPHARYNGITIS 122 0.0007
586 VIRAL INFECTION 22 0.0007
587 CORONARY ARTERY DISEASE 20 0.0007
588 MIGRAINE 63 0.0007
589 URINARY RETENTION 22 0.0007
590 ABDOMINAL DISCOMFORT 110 0.0007
591 PRODUCT QUALITY ISSUE 89 0.0007
592 DECREASED APPETITE 152 0.0007
593 CARDIOMEGALY 8 0.0006
594 PYREXIA 225 0.0006
595 SKIN CANCER 14 0.0006
596 THERAPEUTIC PRODUCT EFFECT DECREASED 29 0.0006
597 ANHEDONIA 17 0.0006
598 MUSCULOSKELETAL CHEST PAIN 10 0.0006
599 ANKLE FRACTURE 10 0.0006
600 WHITE BLOOD CELL COUNT DECREASED 70 0.0006
601 FULL BLOOD COUNT DECREASED 13 0.0006
602 HEPATIC STEATOSIS 12 0.0006
603 BACK INJURY 7 0.0006
604 HAEMATURIA 22 0.0006
605 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
606 SECRETION DISCHARGE 8 0.0006
607 CELLULITIS 32 0.0006
608 GLYCOSYLATED HAEMOGLOBIN INCREASED 16 0.0006
609 HYPERGLYCAEMIA 23 0.0006
610 BRONCHOSPASM 9 0.0006
611 SKIN DISORDER 21 0.0006
612 BLOOD BILIRUBIN INCREASED 17 0.0006
613 HYPERTENSIVE CRISIS 7 0.0006
614 PRODUCTIVE COUGH 30 0.0006
615 RHEUMATOID ARTHRITIS 71 0.0006
616 TYPE 2 DIABETES MELLITUS 21 0.0006
617 NEPHROPATHY TOXIC 7 0.0006
618 LYMPHOCYTE COUNT DECREASED 11 0.0006
619 GASTROOESOPHAGEAL REFLUX DISEASE 50 0.0006
620 DRUG ERUPTION 11 0.0006
621 SKIN ULCER 16 0.0006
622 FLUID OVERLOAD 9 0.0006
623 APATHY 9 0.0006
624 GALLBLADDER DISORDER 11 0.0006
625 IMPAIRED DRIVING ABILITY 7 0.0006
626 CHOLECYSTECTOMY 7 0.0006
627 BLOOD CREATININE INCREASED 40 0.0006
628 HEADACHE 384 0.0006
629 FLUID RETENTION 31 0.0006
630 TOOTH INFECTION 8 0.0006
631 DYSGEUSIA 45 0.0006
632 PHOTOSENSITIVITY REACTION 10 0.0006
633 C-REACTIVE PROTEIN INCREASED 22 0.0006
634 AGEUSIA 15 0.0006
635 HYPOAESTHESIA 90 0.0006
636 SWELLING 56 0.0006
637 MEMORY IMPAIRMENT 82 0.0006
638 UPPER GASTROINTESTINAL HAEMORRHAGE 10 0.0006
639 BLOOD COUNT ABNORMAL 9 0.0006
640 CANDIDA INFECTION 10 0.0006
641 FEEDING DISORDER 12 0.0006
642 PERIPHERAL SWELLING 91 0.0006
643 SYNCOPE 59 0.0006
644 NEUTROPHIL COUNT DECREASED 24 0.0006
645 CHOLECYSTITIS 7 0.0006
646 SKIN DISCOLOURATION 27 0.0006
647 WEIGHT DECREASED 164 0.0006
648 HYPONATRAEMIA 33 0.0006
649 STEVENS-JOHNSON SYNDROME 13 0.0006
650 OROPHARYNGEAL PAIN 54 0.0006
651 INJURY 41 0.0006
652 MUSCLE SPASMS 107 0.0006
653 MUSCULOSKELETAL DISCOMFORT 10 0.0006
654 GASTROINTESTINAL DISORDER 52 0.0006
655 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 17 0.0006
656 BASAL CELL CARCINOMA 9 0.0006
657 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 41 0.0006
658 CARDIAC FAILURE CONGESTIVE 46 0.0006
659 MASS 8 0.0006
660 BLOOD PRESSURE DECREASED 38 0.0006
661 INTENTIONAL PRODUCT MISUSE 50 0.0006
662 COUGH 160 0.0006
663 DYSURIA 21 0.0006
664 DYSPEPSIA 56 0.0006
665 PANCREATITIS 30 0.0006
666 BALANCE DISORDER 49 0.0006
667 PRODUCT DOSE OMISSION IN ERROR 16 0.0006
668 DIABETES MELLITUS INADEQUATE CONTROL 10 0.0006
669 COVID-19 99 0.0006
670 DIALYSIS 8 0.0006
671 SINUS TACHYCARDIA 8 0.0006
672 BONE PAIN 33 0.0006
673 GENERAL PHYSICAL HEALTH DETERIORATION 65 0.0006
674 EPISTAXIS 42 0.0006
675 THERAPEUTIC RESPONSE DECREASED 34 0.0006
676 RENAL DISORDER 26 0.0006
677 BURNING SENSATION 39 0.0006
678 MYELOSUPPRESSION 20 0.0006
679 BLOOD POTASSIUM INCREASED 9 0.0006
680 PRODUCT PRESCRIBING ISSUE 12 0.0006
681 PRODUCT USE IN UNAPPROVED INDICATION 136 0.0005
682 SKIN LESION 15 0.0005
683 ASCITES 16 0.0005
684 ILL-DEFINED DISORDER 33 0.0005
685 BONE MARROW FAILURE 11 0.0005
686 TRANSAMINASES INCREASED 12 0.0005
687 RENAL INJURY 16 0.0005
688 DEMENTIA 15 0.0005
689 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 28 0.0005
690 ABDOMINAL DISTENSION 56 0.0005
691 NODULE 7 0.0005
692 BLOOD CHOLESTEROL INCREASED 25 0.0005
693 HAEMORRHAGE INTRACRANIAL 8 0.0005
694 ACCIDENTAL EXPOSURE TO PRODUCT 55 0.0005
695 JOINT STIFFNESS 14 0.0005
696 HYPOAESTHESIA ORAL 8 0.0005
697 BACK PAIN 123 0.0005
698 TACHYCARDIA 47 0.0005
699 DEEP VEIN THROMBOSIS 34 0.0005
700 AMNESIA 34 0.0005
701 PULMONARY FIBROSIS 10 0.0005
702 WHITE BLOOD CELL COUNT INCREASED 20 0.0005
703 PRODUCT SUBSTITUTION ISSUE 30 0.0005
704 PNEUMONIA ASPIRATION 13 0.0005
705 DEVICE RELATED INFECTION 8 0.0005
706 EXTRA DOSE ADMINISTERED 21 0.0005
707 ORTHOSTATIC HYPOTENSION 9 0.0005
708 FALL 172 0.0005
709 PARAESTHESIA 81 0.0005
710 DRUG TOXICITY 7 0.0005
711 PULMONARY OEDEMA 23 0.0005
712 ORAL HERPES 10 0.0005
713 COLD SWEAT 9 0.0005
714 LIP SWELLING 17 0.0005
715 ARTHRALGIA 212 0.0005
716 DEHYDRATION 68 0.0005
717 THROMBOCYTOPENIA 57 0.0005
718 BRADYCARDIA 27 0.0005
719 GAIT INABILITY 17 0.0005
720 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
721 RASH 221 0.0005
722 URINARY INCONTINENCE 15 0.0005
723 SEPTIC SHOCK 22 0.0005
724 DIZZINESS 252 0.0005
725 CLOSTRIDIUM DIFFICILE INFECTION 11 0.0005
726 MEDICATION ERROR 28 0.0005
727 ORAL DISCOMFORT 7 0.0005
728 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 17 0.0005
729 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
730 HYPOMAGNESAEMIA 7 0.0005
731 MUSCULOSKELETAL STIFFNESS 44 0.0005
732 HAEMOPTYSIS 14 0.0005
733 ADVERSE DRUG REACTION 45 0.0005
734 HYPOTHYROIDISM 16 0.0005
735 BLOOD PRESSURE FLUCTUATION 12 0.0005
736 CONSTIPATION 109 0.0005
737 DEVICE OCCLUSION 7 0.0005
738 DEAFNESS 13 0.0005
739 PRODUCT PHYSICAL ISSUE 10 0.0005
740 MENTAL IMPAIRMENT 12 0.0005
741 FATIGUE 385 0.0005
742 RASH MACULO-PAPULAR 11 0.0005
743 NASAL CONGESTION 29 0.0005
744 INTENTIONAL DOSE OMISSION 14 0.0005
745 ANGINA PECTORIS 14 0.0005
746 CHOLELITHIASIS 16 0.0005
747 HYPOACUSIS 21 0.0005
748 HEART RATE IRREGULAR 11 0.0005
749 PAIN IN EXTREMITY 143 0.0005
750 VENTRICULAR TACHYCARDIA 8 0.0005
751 PRODUCT AVAILABILITY ISSUE 11 0.0005
752 NECK PAIN 27 0.0005
753 DRUG EFFECT DECREASED 26 0.0005
754 DYSPNOEA 273 0.0005
755 LYMPHADENOPATHY 17 0.0005
756 DYSSTASIA 14 0.0005
757 PAIN 294 0.0005
758 HYPOTENSION 96 0.0005
759 SURGERY 28 0.0005
760 INFLUENZA 53 0.0005
761 ACUTE MYOCARDIAL INFARCTION 14 0.0005
762 DIARRHOEA 306 0.0005
763 PSYCHOTIC DISORDER 14 0.0005
764 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 8 0.0005
765 DRY MOUTH 38 0.0005
766 GAIT DISTURBANCE 89 0.0005
767 ACCIDENTAL OVERDOSE 17 0.0005
768 HEPATIC FAILURE 14 0.0005
769 RENAL IMPAIRMENT 39 0.0005
770 HAEMATOMA 12 0.0005
771 SKIN FISSURES 9 0.0005
772 ASTHENIA 173 0.0005
773 PRURITUS 176 0.0005
774 HIP ARTHROPLASTY 7 0.0005
775 OSTEONECROSIS 15 0.0005
776 DISEASE PROGRESSION 54 0.0005
777 ILLNESS 47 0.0005
778 POLLAKIURIA 19 0.0005
779 WEIGHT INCREASED 102 0.0005
780 CHEST PAIN 84 0.0005
781 INTESTINAL OBSTRUCTION 17 0.0005
782 PREGNANCY 9 0.0004
783 SPINAL FRACTURE 9 0.0004
784 HEPATOTOXICITY 10 0.0004
785 LIVER FUNCTION TEST ABNORMAL 13 0.0004
786 BRAIN FOG 7 0.0004
787 GOUT 8 0.0004
788 PRODUCT DOSE OMISSION 29 0.0004
789 THROAT TIGHTNESS 12 0.0004
790 VERTIGO 27 0.0004
791 LEUKOPENIA 22 0.0004
792 CYSTITIS 14 0.0004
793 DEVICE DELIVERY SYSTEM ISSUE 12 0.0004
794 NEPHROLITHIASIS 20 0.0004
795 CHILLS 51 0.0004
796 RESPIRATORY DISORDER 13 0.0004
797 PRODUCT STORAGE ERROR 38 0.0004
798 MUSCLE TWITCHING 10 0.0004
799 DIVERTICULITIS 12 0.0004
800 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 78 0.0004
801 ANAEMIA 82 0.0004
802 RASH MACULAR 15 0.0004
803 DRUG RESISTANCE 11 0.0004
804 INSOMNIA 114 0.0004
805 OXYGEN SATURATION DECREASED 24 0.0004
806 PALPITATIONS 50 0.0004
807 ANAPHYLACTIC SHOCK 11 0.0004
808 MANIA 7 0.0004
809 BLOOD SODIUM DECREASED 8 0.0004
810 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 86 0.0004
811 THROAT IRRITATION 19 0.0004
812 HYPOCALCAEMIA 8 0.0004
813 BLOOD URINE PRESENT 8 0.0004
814 EXPIRED PRODUCT ADMINISTERED 14 0.0004
815 IMPAIRED WORK ABILITY 9 0.0004
816 LIMB DISCOMFORT 13 0.0004
817 FEELING JITTERY 8 0.0004
818 NEUTROPENIA 57 0.0004
819 GASTRITIS 11 0.0004
820 DIABETIC KETOACIDOSIS 10 0.0004
821 FACE OEDEMA 7 0.0004
822 BLOOD GLUCOSE INCREASED 78 0.0004
823 ABDOMINAL PAIN UPPER 85 0.0004
824 HOT FLUSH 31 0.0004
825 TREMOR 68 0.0004
826 KIDNEY INFECTION 8 0.0004
827 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 29 0.0004
828 FREQUENT BOWEL MOVEMENTS 11 0.0004
829 ASTHMA 46 0.0004
830 LABORATORY TEST ABNORMAL 12 0.0004
831 ROAD TRAFFIC ACCIDENT 17 0.0004
832 PNEUMONITIS 11 0.0004
833 ALOPECIA 79 0.0004
834 TREATMENT NONCOMPLIANCE 22 0.0004
835 DYSPHAGIA 38 0.0004
836 PREMATURE BABY 12 0.0004
837 MENTAL STATUS CHANGES 11 0.0004
838 DEPRESSION 90 0.0004
839 ABDOMINAL PAIN 92 0.0004
840 FEELING COLD 11 0.0004
841 PRODUCT PREPARATION ERROR 8 0.0004
842 PULMONARY EMBOLISM 37 0.0004
843 TOOTHACHE 7 0.0004
844 PERITONITIS 8 0.0004
845 PELVIC PAIN 7 0.0004
846 ERYTHEMA 79 0.0004
847 CONFUSIONAL STATE 62 0.0004
848 KNEE ARTHROPLASTY 8 0.0004
849 GASTRIC DISORDER 13 0.0004
850 ANXIETY 107 0.0004
851 POOR QUALITY SLEEP 8 0.0004
852 CHEST DISCOMFORT 38 0.0004
853 FAECES DISCOLOURED 8 0.0004
854 ADVERSE EVENT 34 0.0004
855 MUSCULOSKELETAL DISORDER 7 0.0004
856 LETHARGY 21 0.0004
857 EMOTIONAL DISTRESS 44 0.0004
858 RESPIRATORY DISTRESS 10 0.0004
859 ERUCTATION 7 0.0004
860 CARDIAC FAILURE 29 0.0004
861 PROCEDURAL PAIN 10 0.0004
862 URTICARIA 60 0.0004
863 NAUSEA 281 0.0004
864 CHROMATURIA 8 0.0004
865 BLOOD GLUCOSE DECREASED 17 0.0004
866 DISORIENTATION 14 0.0004
867 HEART RATE INCREASED 35 0.0004
868 FLATULENCE 20 0.0004
869 MALAISE 154 0.0004
870 HYPOGLYCAEMIA 17 0.0004
871 INCORRECT DOSE ADMINISTERED 80 0.0004
872 METABOLIC ACIDOSIS 11 0.0003
873 ECZEMA 18 0.0003
874 MUCOSAL INFLAMMATION 9 0.0003
875 BODY TEMPERATURE INCREASED 7 0.0003
876 PRODUCT PRESCRIBING ERROR 8 0.0003
877 CEREBRAL HAEMORRHAGE 12 0.0003
878 RASH ERYTHEMATOUS 16 0.0003
879 HOSPITALISATION 51 0.0003
880 VOMITING 156 0.0003
881 HALLUCINATION, VISUAL 7 0.0003
882 DRY SKIN 44 0.0003
883 MYALGIA 56 0.0003
884 EATING DISORDER 7 0.0003
885 ANGER 11 0.0003
886 PRURITUS GENERALISED 7 0.0003
887 DEVICE DISLOCATION 14 0.0003
888 EXPOSURE DURING PREGNANCY 20 0.0003
889 DRUG INTERACTION 51 0.0003
890 PSORIATIC ARTHROPATHY 13 0.0003
891 LOSS OF CONSCIOUSNESS 41 0.0003
892 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
893 INFLUENZA LIKE ILLNESS 26 0.0003
894 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
895 DIABETES MELLITUS 24 0.0003
896 FLUSHING 32 0.0003
897 MULTIPLE SCLEROSIS 15 0.0003
898 RASH PRURITIC 17 0.0003
899 MOVEMENT DISORDER 10 0.0003
900 CARDIO-RESPIRATORY ARREST 13 0.0003
901 WITHDRAWAL SYNDROME 13 0.0003
902 RASH GENERALISED 8 0.0003
903 SOMNOLENCE 62 0.0003
904 DYSPHONIA 18 0.0003
905 PLASMA CELL MYELOMA 12 0.0003
906 SHOCK 7 0.0003
907 AGITATION 22 0.0003
908 IRRITABILITY 18 0.0003
909 CARDIAC DISORDER 28 0.0003
910 FEAR 8 0.0003
911 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
912 SKIN EXFOLIATION 25 0.0003
913 ARRHYTHMIA 14 0.0003
914 FEELING HOT 18 0.0003
915 HALLUCINATION 22 0.0003
916 UNEVALUABLE EVENT 22 0.0003
917 FEMUR FRACTURE 9 0.0003
918 HAEMATOCHEZIA 16 0.0003
919 ANAPHYLACTIC REACTION 16 0.0003
920 INJECTION SITE URTICARIA 7 0.0003
921 DERMATITIS ATOPIC 15 0.0003
922 DEPRESSED MOOD 15 0.0003
923 HYPERSOMNIA 8 0.0003
924 ABDOMINAL PAIN LOWER 7 0.0003
925 GASTRIC CANCER 7 0.0003
926 HAEMATEMESIS 7 0.0003
927 INJECTION SITE BRUISING 22 0.0003
928 CRYING 10 0.0003
929 HEPATITIS 7 0.0003
930 THROMBOSIS 22 0.0003
931 MALIGNANT NEOPLASM PROGRESSION 28 0.0003
932 HYPERHIDROSIS 35 0.0003
933 THERAPEUTIC RESPONSE SHORTENED 9 0.0003
934 DEVICE ISSUE 24 0.0003
935 DYSARTHRIA 10 0.0003
936 JAUNDICE 7 0.0003
937 PAIN OF SKIN 7 0.0003
938 EMOTIONAL DISORDER 8 0.0003
939 PALLOR 7 0.0003
940 NERVOUS SYSTEM DISORDER 8 0.0003
941 SWOLLEN TONGUE 8 0.0003
942 DEVICE LEAKAGE 11 0.0003
943 MOOD SWINGS 8 0.0003
944 INCORRECT DRUG ADMINISTRATION DURATION 7 0.0002
945 WRONG TECHNIQUE IN DRUG USAGE PROCESS 9 0.0002
946 FEELING ABNORMAL 59 0.0002
947 FOETAL EXPOSURE DURING PREGNANCY 20 0.0002
948 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
949 SEIZURE 28 0.0002
950 DEVICE DIFFICULT TO USE 16 0.0002
951 INJECTION SITE PRURITUS 16 0.0002
952 CEREBROVASCULAR ACCIDENT 40 0.0002
953 INJECTION SITE ERYTHEMA 29 0.0002
954 NERVOUSNESS 12 0.0002
955 HAEMORRHAGE 24 0.0002
956 DRUG ADMINISTRATION ERROR 7 0.0002
957 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
958 MYOCARDIAL INFARCTION 39 0.0002
959 DISTURBANCE IN ATTENTION 12 0.0002
960 INJECTION SITE SWELLING 17 0.0002
961 RESTLESSNESS 8 0.0002
962 INJECTION SITE REACTION 15 0.0002
963 INJECTION SITE MASS 8 0.0002
964 PROSTATE CANCER 17 0.0002
965 INJECTION SITE PAIN 63 0.0002
966 ABNORMAL BEHAVIOUR 8 0.0002
967 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
968 ACNE 15 0.0002
969 NEOPLASM MALIGNANT 13 0.0002
970 CONVULSION 11 0.0002
971 UNDERDOSE 14 0.0002
972 DRUG DOSE OMISSION BY DEVICE 15 0.0002
973 SPEECH DISORDER 10 0.0002
974 INJECTION SITE HAEMORRHAGE 15 0.0002
975 DEATH 157 0.0002
976 DRUG DOSE OMISSION 29 0.0002
977 MULTIPLE SCLEROSIS RELAPSE 12 0.0002
978 SKIN IRRITATION 8 0.0002
979 COGNITIVE DISORDER 8 0.0002
980 LUNG NEOPLASM MALIGNANT 7 0.0002
981 TOXICITY TO VARIOUS AGENTS 28 0.0002
982 SUICIDAL IDEATION 15 0.0002
983 CARDIAC ARREST 13 0.0002
984 THERAPY CESSATION 8 0.0002
985 BREAST CANCER 13 0.0001
986 PSORIASIS 17 0.0001
987 OVERDOSE 26 0.0001
988 SKIN BURNING SENSATION 8 0.0001
989 DRUG WITHDRAWAL SYNDROME 8 0.0001
990 DRUG DEPENDENCE 12 0.0001